GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (XMAD:PHM) » Definitions » Median PS Value

Pharma Mar (XMAD:PHM) Median PS Value : €39.00 (As of May. 22, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Pharma Mar Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Pharma Mar's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €9.14. Pharma Mar's 10-Year median PS Ratio is 4.267. Therefore, the Median PS Value for today is €39.00.

As of today (2024-05-22), Pharma Mar's share price is €36.02. Pharma Mar's Median PS Value is €39.00. Therefore, Pharma Mar's Price to Median PS Value for today is 0.92.

The historical rank and industry rank for Pharma Mar's Median PS Value or its related term are showing as below:

XMAD:PHM' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.64   Med: 1.23   Max: 2.72
Current: 0.92

During the past 13 years, the highest Price to Median PS Value of Pharma Mar was 2.72. The lowest was 0.64. And the median was 1.23.

XMAD:PHM's Price-to-Median-PS-Value is ranked worse than
62.6% of 262 companies
in the Biotechnology industry
Industry Median: 0.695 vs XMAD:PHM: 0.92

Pharma Mar Median PS Value Historical Data

The historical data trend for Pharma Mar's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar Median PS Value Chart

Pharma Mar Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.73 49.86 48.04 46.03 38.14

Pharma Mar Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.75 41.34 39.92 38.14 39.00

Competitive Comparison of Pharma Mar's Median PS Value

For the Biotechnology subindustry, Pharma Mar's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Mar's Price-to-Median-PS-Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Mar's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Pharma Mar's Price-to-Median-PS-Value falls into.



Pharma Mar Median PS Value Calculation

Pharma Mar's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=9.14*4.267
=39.00

10-Year Median PS Ratio is 4.267.
Pharma Mar's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €9.14.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharma Mar  (XMAD:PHM) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Pharma Mar's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=36.02/39.00
=0.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharma Mar Median PS Value Related Terms

Thank you for viewing the detailed overview of Pharma Mar's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharma Mar (XMAD:PHM) Business Description

Traded in Other Exchanges
Address
Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.

Pharma Mar (XMAD:PHM) Headlines